Buresová I - Search Results

1

Sample processing and methodological pitfalls in multiple myeloma research.

Potácová A, Stossová J, Buresová I, Kovárová L, Almási M, Penka M, Hájek R. Potácová A, et al. Among authors: buresova i. Klin Onkol. 2011;24 Suppl:S18-23. Klin Onkol. 2011. PMID: 21923059 Review.

2

Optimization of immunomagnetic selection of myeloma cells from bone marrow using magnetic activated cell sorting.

Cumova J, Kovarova L, Potacova A, Buresova I, Kryukov F, Penka M, Michalek J, Hajek R. Cumova J, et al. Among authors: buresova i. Int J Hematol. 2010 Sep;92(2):314-9. doi: 10.1007/s12185-010-0651-4. Epub 2010 Aug 7. Int J Hematol. 2010. PMID: 20694533

3

[Plasma cell separation algorithm from bone marrow samples].

Buresová I, Kyjovská D, Kovárová L, Moravcová J, Suská R, Perutka T, Cumová J, Hájek R. Buresová I, et al. Klin Onkol. 2011;24(1):35-40. Klin Onkol. 2011. PMID: 21542274 Czech.

4

In vitro activation of cytotoxic T-lymphocytes by hTERT-pulsed dendritic cells.

Kryukov F, Ocadlíková D, Kovárová L, Buresová I, Hájek R, Michálek J. Kryukov F, et al. Among authors: buresova i. J Immunotoxicol. 2009 Dec;6(4):243-8. doi: 10.3109/15476910903236134. J Immunotoxicol. 2009. PMID: 19908943 Free article.

5

Phenotype of plasma cells in multiple myeloma and monoclonal gammopathy of undetermined significance.

Kovarova L, Buresova I, Buchler T, Suska R, Pour L, Zahradova L, Penka M, Hajek R. Kovarova L, et al. Among authors: buresova i. Neoplasma. 2009;56(6):526-32. doi: 10.4149/neo_2009_06_526. Neoplasma. 2009. PMID: 19728762

6

Bone marrow plasma cell separation - validation of separation algorithm.

Buresova I, Cumova J, Kovarova L, Stossova J, Dementyeva E, Kryukov F, Sevcikova S, Svachova H, Hajek R. Buresova I, et al. Clin Chem Lab Med. 2012 Jan 31;50(6):1139-40. doi: 10.1515/cclm-2012-8837. Clin Chem Lab Med. 2012. PMID: 22706262 No abstract available.

7

Bone marrow plasma cell separation - validation of separation algorithm.

Buresova I, Cumova J, Kovarova L, Stossova J, Dementyeva E, Kryukov F, Sevcikova S, Svachova H, Hajek R. Buresova I, et al. Clin Chem Lab Med. 2012 Feb 1:/j/cclm.ahead-of-print/cclm-2011-0837/cclm-2011-0837.xml. doi: 10.1515/cclm-2011-0837. Online ahead of print. Clin Chem Lab Med. 2012. PMID: 23095232 No abstract available.

8

Selective depletion of alloreactive donor T cells leads to elimination of graft-versus-host reactivity and stimulates graft-versus-leukaemia/myeloma effect.

Matějková E, Foltánková V, Burešová I. Matějková E, et al. Among authors: buresova i. Folia Biol (Praha). 2013;59(4):146-53. Folia Biol (Praha). 2013. PMID: 24093772 Free article.

9

Complex evaluation of human monocyte-derived dendritic cells for cancer immunotherapy.

Vopenkova K, Mollova K, Buresova I, Michalek J. Vopenkova K, et al. Among authors: buresova i. J Cell Mol Med. 2012 Nov;16(11):2827-37. doi: 10.1111/j.1582-4934.2012.01614.x. J Cell Mol Med. 2012. PMID: 22882679 Free PMC article.

10

microRNA-342, microRNA-191 and microRNA-510 are differentially expressed in T regulatory cells of type 1 diabetic patients.

Hezova R, Slaby O, Faltejskova P, Mikulkova Z, Buresova I, Raja KR, Hodek J, Ovesna J, Michalek J. Hezova R, et al. Among authors: buresova i. Cell Immunol. 2010;260(2):70-4. doi: 10.1016/j.cellimm.2009.10.012. Cell Immunol. 2010. PMID: 19954774

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

27 results

Search Page

Filters